vs
Side-by-side financial comparison of Brookfield Infrastructure Corp (BIPC) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.
Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $866.0M, roughly 1.7× Brookfield Infrastructure Corp). Option Care Health, Inc. runs the higher net margin — 3.6% vs -35.7%, a 39.3% gap on every dollar of revenue. On growth, Option Care Health, Inc. posted the faster year-over-year revenue change (12.2% vs -4.6%).
Brookfield Infrastructure Partners L.P. is a publicly traded limited partnership with corporate headquarters in Toronto, Canada, that engages in the acquisition and management of infrastructure assets on a global basis.
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
BIPC vs OPCH — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $866.0M | $1.4B |
| Net Profit | $-309.0M | $51.8M |
| Gross Margin | 65.0% | 19.0% |
| Operating Margin | 62.7% | 5.9% |
| Net Margin | -35.7% | 3.6% |
| Revenue YoY | -4.6% | 12.2% |
| Net Profit YoY | -148.1% | -3.8% |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $1.4B | ||
| Q2 25 | $866.0M | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $908.0M | $1.2B | ||
| Q1 24 | — | $1.1B | ||
| Q4 23 | — | $1.1B |
| Q3 25 | — | $51.8M | ||
| Q2 25 | $-309.0M | $50.5M | ||
| Q1 25 | — | $46.7M | ||
| Q4 24 | — | $60.1M | ||
| Q3 24 | — | $53.9M | ||
| Q2 24 | $643.0M | $53.0M | ||
| Q1 24 | — | $44.8M | ||
| Q4 23 | — | — |
| Q3 25 | — | 19.0% | ||
| Q2 25 | 65.0% | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | 63.8% | 20.3% | ||
| Q1 24 | — | 20.8% | ||
| Q4 23 | — | 22.0% |
| Q3 25 | — | 5.9% | ||
| Q2 25 | 62.7% | 5.8% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | 61.9% | 6.6% | ||
| Q1 24 | — | 6.0% | ||
| Q4 23 | — | 7.5% |
| Q3 25 | — | 3.6% | ||
| Q2 25 | -35.7% | 3.6% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | 70.8% | 4.3% | ||
| Q1 24 | — | 3.9% | ||
| Q4 23 | — | — |
| Q3 25 | — | $0.32 | ||
| Q2 25 | — | $0.31 | ||
| Q1 25 | — | $0.28 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | — | $0.31 | ||
| Q2 24 | — | $0.30 | ||
| Q1 24 | — | $0.26 | ||
| Q4 23 | — | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $309.8M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $2.2B | $1.4B |
| Total Assets | $23.9B | $3.5B |
| Debt / EquityLower = less leverage | — | 0.86× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $309.8M | ||
| Q2 25 | $1.2B | $198.8M | ||
| Q1 25 | — | $171.4M | ||
| Q4 24 | — | $412.6M | ||
| Q3 24 | — | $483.0M | ||
| Q2 24 | $466.0M | $376.9M | ||
| Q1 24 | — | $219.5M | ||
| Q4 23 | — | $343.8M |
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B | ||
| Q4 23 | — | $1.1B |
| Q3 25 | — | $1.4B | ||
| Q2 25 | $2.2B | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $3.5B | $1.4B | ||
| Q1 24 | — | $1.4B | ||
| Q4 23 | — | $1.4B |
| Q3 25 | — | $3.5B | ||
| Q2 25 | $23.9B | $3.4B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | $23.7B | $3.3B | ||
| Q1 24 | — | $3.2B | ||
| Q4 23 | — | $3.2B |
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× | ||
| Q4 23 | — | 0.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $478.0M | $139.4M |
| Free Cash FlowOCF − Capex | — | $130.2M |
| FCF MarginFCF / Revenue | — | 9.1% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | — | 2.69× |
| TTM Free Cash FlowTrailing 4 quarters | — | $220.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $139.4M | ||
| Q2 25 | $478.0M | $90.3M | ||
| Q1 25 | — | $-7.2M | ||
| Q4 24 | — | $36.1M | ||
| Q3 24 | — | $160.4M | ||
| Q2 24 | $511.0M | $195.7M | ||
| Q1 24 | — | $-68.8M | ||
| Q4 23 | — | $51.0M |
| Q3 25 | — | $130.2M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | — | $25.8M | ||
| Q3 24 | — | $150.7M | ||
| Q2 24 | — | $185.9M | ||
| Q1 24 | — | $-74.6M | ||
| Q4 23 | — | $31.1M |
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | -6.5% | ||
| Q4 23 | — | 2.8% |
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.5% | ||
| Q4 23 | — | 1.8% |
| Q3 25 | — | 2.69× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 2.98× | ||
| Q2 24 | 0.79× | 3.69× | ||
| Q1 24 | — | -1.54× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIPC
Segment breakdown not available.
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
